Fulton Bank’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Fulton Bank's DGX Position: Q2 2026 in Review
Fulton Bank reduced its Quest Diagnostics (DGX) stake by 2.4% in Q2 2026, selling an estimated $20K and leaving 4,172 shares worth $884K. The position accounts for 0.03% of the portfolio, ranked #351.
Fulton Bank first reported a position in DGX in Q2 2019 and has held it in 9 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Fulton Bank held 4,172 shares of Quest Diagnostics worth $884K as of Q2 2026.
- Fulton Bank sold 102 Quest Diagnostics shares in Q2 2026, an estimated $20K.
- Quest Diagnostics made up 0.03% of Fulton Bank's portfolio in Q2 2026, its #351 holding.
- Fulton Bank first reported a position in Quest Diagnostics in Q2 2019 and has held it in 9 quarters since.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.